Impact of Multimorbidity on Symptom Burden and Symptom Clusters in Patients Receiving Chemotherapy
Findings suggest that higher multimorbidity is associated with various social determinants of health and a higher symptom burden. Differences between multimorbidity groups may be related to aging, treatments, and/or comorbid conditions.
Authors
- Yvette P. Conley (ORCID: https://orcid.org/0000-0002-1784-6067)
- Jon D. Levine (ORCID: https://orcid.org/0000-0003-0681-5545)
- Carolyn Harris (ORCID: https://orcid.org/0000-0002-7080-4990)
- Joosun Shin (ORCID: https://orcid.org/0000-0001-6883-4448)
- Marilyn J. Hammer (ORCID: https://orcid.org/0000-0002-9561-6144)
- Bruce A. Cooper (ORCID: https://orcid.org/0000-0001-8932-4113)
- Lisa Morse (ORCID: https://orcid.org/0000-0001-9490-8906)
- Kate Oppegaard (ORCID: https://orcid.org/0000-0002-6358-6315)
- Christine Miaskowski (ORCID: https://orcid.org/0000-0001-5170-2027)
- Steven M. Paul
Institutions
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Dana-Farber Cancer Institute (US)
- VA Portland Health Care System (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/cam4.70418
- Citations
- 13
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 17.60
Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Cancer Institute